Enko Launches with $66 Million in Funding to Deliver Products that Enable Farmers to Protect Crops From Pests and Disease

Top Investors Led by the Bill & Melinda Gates Foundation Back Series B as Global Demand for Sustainable Agriculture Practices Intensifies

Woburn, Mass. – June 26, 2020 — Aiming to kick-start the crop protection industry’s stalled R&D pipelines to develop novel, safer products for the global farming community, Enko Chem Inc. (Enko) today publicly launched after securing $45 million in a Series B round of financing, bringing its total funding raised to date to $66 million. Led by the Bill & Melinda Gates Foundation, the latest round attracted a strong mix of existing (Anterra Capital and Rabo Food & Agri Innovation Fund) and new investors (Finistere Ventures, Novalis LifeSciences, Germin8 Ventures, TO Ventures Food).

“Development pipelines for new agriculture chemicals have atrophied. A lack of new discovery platforms has increased costs, and rising regulation has taken the spotlight off of traditional chemistry. Reinvigorating traditional ag chemistry, Enko’s technology is one-of-a-kind and will help move the needle on crop protection to secure the food supply chain.”

-- Spencer Maughan, partner Finistere Ventures.

We’re committed to ensuring that smallholder farming communities in sub-Saharan Africa and South Asia have access to affordable innovations that can safely and sustainably control crop pests and diseases, which are likely to intensify and spread into new areas due to climate change,” said Dr. Vipula Shukla, Senior Program Officer, Agriculture, Bill & Melinda Gates Foundation.  “Smallholder farmers are the backbone of the agricultural economy in these regions, so working with innovative companies like Enko Chem to equip them with better ways to fight these threats is crucial to building their resilience to climate impacts on food and feed production.”

The crop protection industry is struggling to face critical challenges including rising regulatory standards, higher performance requirements, and growing pest resistance. At a time when more than 600 pest species have developed some form of resistance and threaten yield losses of up to 40 percent, industry R&D pipelines have suffered a declining rate of innovation and have failed to deliver high-value new products when producers and consumers need it the most. Enko is pioneering a new approach by integrating complementary technologies to develop improved products that meet or exceed the safety and sustainability demands of farmers, consumers and regulators around the globe.

“Resistance issues have been plaguing agriculture production for years, but the industry has been slow to innovate. Delivering safer, lower use rate products that provide good returns for farmers needs to be the rule and not the exception,” said Jacqueline Heard, CEO of Enko. “We are leveraging powerful drug discovery technologies to build a deep pipeline of solutions at unprecedented speed as we strive to lead this $60 billion industry into a new era of sustainable agriculture. We are thrilled that our novel approach, which builds in safety measures from the start to keep us ahead of future needs, has attracted support from this top-tier group of investors.”

Founded in 2017 and incubated by Anterra Capital, Enko will use the funds to expand its technology platform and rapidly develop its pipeline of novel crop protection products. Using advanced pharmaceutical discovery and predictive analytics tools, the company is actively advancing novel modes of action through its platform, and its first solutions are progressing toward field testing and regulatory trials. In support of this mission, Enko continues to cultivate research collaboration and strategic partnerships with industry leaders.

Marijn Dekkers, founder and chairman of Novalis LifeSciences, and Spencer Maughan, co-founder and partner at Finistere Ventures, will join Enko’s Board of Directors to support the company’s pursuit of new modes of actions for novel small molecule solutions that will revitalize the industry’s stagnant crop protection pipeline.

About Enko
Enko discovers and develops novel products for farmers to protect their crops from pests and disease. Its proprietary technology platform represents a revolutionary approach to rapidly discover safe and economical solutions that are needed to ensure sustainable food production. Led by a team of proven scientists, entrepreneurs and ag-industry veterans, Enko’s innovative science, agile design, and discovery of new modes of action is producing next-generation crop protection solutions that will overcome the critical challenges facing industry. For more information, visit www.enkochem.com.

Media Contacts:
Erica Camilo
Connexa Communications for Enko
C: 610.639.5644
Erica@connexacommunications.com

Additional Finistere Insights

Hi Fidelity Genetics Announces Study Published in the Proceedings of the National Academy of Sciences

Hi Fidelity Genetics Announces Study Published in the Proceedings of the National Academy of Sciences Peer-Reviewed Journal Details How to Dramatically Reduce Row Crop Emissions and Make Farm Management Practices More Sustainable DURHAM, N.C., June 21, 2021 – Hi Fidelity Genetics (HFG), a computational crop breeding company, announced today the publication of a peer-reviewed article titled, “Novel… Read More ▸

ZeaKal Unveils Breakthrough High-Oil Hemp Results

ZEAKAL’S NOVEL PHOTOSEED TRAIT BOOSTS HEMP BIOMASS OIL OUTPUT BY UP TO 50% TORONTO and SAN DIEGO – June 1, 2021 – RIV Capital Inc. (“RIV Capital” or the “Company”) (TSX: RIV, OTC: CNPOF) and Finistere Ventures portfolio company ZeaKal, Inc. (“ZeaKal”) announced that its PhotoSeed™ technology is believed to be the first plant trait… Read More ▸

Finistere Ventures 2020 Agrifood Tech Investment Review

Agrifood tech, defiant in face of pandemic, records breakout fundraising year. As COVID-19 reshaped the world, the agrifood tech investment community reacted quickly to the extreme uncertainty. The result was a record-shattering investment sum of $22.3 billion committed to the space in aggregate in 2020—momentum that has carried into this year. The resilience of investment… Read More ▸